Pharmaceutical benefits supplied under a special arrangement
16AAA Pharmaceutical benefits supplied under a special arrangement
A Community Pharmacist will be required to supply a Pharmaceutical benefit to an Eligible Person under a special arrangement if:
the supply is made in accordance with the conditions specified in the National Health (COVID‑19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 as in force from time to time:
as if the supply under the Scheme is a supply covered by the instrument; and
the instrument has effect under subsections (2), (3), (4), (5), (6), (7), (8), (9), (10) and (11) of this section; and
to the extent that those conditions are applicable to the supply; and
the supply of the Pharmaceutical benefit occurs before the repeal of the National Health (COVID‑19 Supply of Pharmaceutical Benefits) Special Arrangement 2020;
the supply otherwise conforms to this section.
For the purposes of paragraph (1)(a) of this section, the National Health (COVID‑19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 has effect in accordance with the following table.
Modified effect of the National Health (COVID‑19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 instrument | ||
|---|---|---|
Item | Column 1 The instrument has effect as if a reference to … | Column 2 were a reference to … |
1 | a paper‑based repeat authorisation | a repeat authorisation form |
2 | a PBS prescriber | a person who prescribes a Pharmaceutical benefit under the Scheme |
3 | a pharmaceutical benefit | a Pharmaceutical benefit |
4 | an approved hospital authority | an Approved Hospital Authority |
5 | an approved pharmacist | a Community Pharmacist |
6 | a CTS claim | a claim under the claims rules |
7 | Part VII of the Act | the Scheme |
8 | section 44 of the Regulations | section 16 of the Scheme |
9 | subsections 40(1), (2) and (2A) of the Regulations | subsections 11A(1) and (1A) of the Scheme |
10 | subsection 40(2) of the Regulations | subsection 11A(1) of the Scheme |
Further modifications of the instrument
The special arrangement referred to in paragraph (1)(a) has effect as if the definition of “approved hospital authority” in subsection 6(1) of the instrument is omitted.
The special arrangement referred to in paragraph (1)(a) has effect as if the definition of “approved hospital authority dispenser” in subsection 6(1) of the instrument is replaced with the following:
approved hospital authority dispenser means the Community Pharmacist or approved medical practitioner by whom, or under whose supervision, a Pharmaceutical benefit supplied by an Approved Hospital Authority will be dispensed.
The special arrangement referred to in paragraph (1)(a) has effect as if the definition of “CTS claim” in subsection 6(1) of the instrument is omitted.
The special arrangement referred to in paragraph (1)(a) has effect as if the definition of “medication chart prescription” in subsection 6(1) of the instrument is replaced with the following:
medication chart prescription has the same meaning as in the Scheme.
The special arrangement referred to in paragraph (1)(a) has effect as if the definition of “paper‑based prescription” in subsection 6(1) of the instrument is replaced with the following:
paper‑based prescription has the same meaning as in the Scheme.
The special arrangement referred to in paragraph (1)(a) has effect as if section 8 of the instrument is replaced with the following:
8 Application of the Scheme
A provision of the Scheme applies subject to this Special Arrangement.
The special arrangement referred to in paragraph (1)(a) has effect as if subsection 9(1) was omitted and replaced with the following:
Division 2 of Part 2 of this Special Arrangement applies to the supply of a pharmaceutical benefit by an approved supplier based on a paper‑based prescription (excluding a medication chart prescription) written as the result of a telehealth attendance or phone attendance provided on or after 20 March 2020 to which an item in a Fee Schedule (a document incorporated as in force from time to time for the purposes of the Treatment Principles) applies.
The special arrangement referred to in paragraph (1)(a) has effect as if subsection 9(4) of the instrument is omitted.
The special arrangement referred to in paragraph (1)(a) has effect as if subsection 10(4) of the instrument is replaced with the following:
If the prescription is or would be an authority prescription, the supplier may supply the Pharmaceutical benefit under this section only if prior approval has been obtained.
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.